• NEBANNER

Good quality Lurasidone Hydrochloride - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Good quality Lurasidone Hydrochloride - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We persistently execute our spirit of ''Innovation bringing growth, Highly-quality making sure subsistence, Administration marketing reward, Credit history attracting clients for Zuclopenthixol Depot, Under Counter Water Filter System, Industrial Wastewater Treatment Systems, We welcome you to join us in this path of creating a prosperous and efficient business together.
Good quality Lurasidone Hydrochloride - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN Detail:

It works by stimulating central presynaptic alpha 2- receptors. Its hypotensive effect is similar to that of nifedipine, a calcium antagonist, and captopril, an ACE inhibitor. For essential hypertension.

This product should adopt the principle of individualized medication. Generally start from the lowest dose, that is, 0.2mg, once a day, taken in the morning. Dosage adjustments should be made at three-week intervals until satisfactory results are obtained. The usual dose is 0.2mg once, twice a day (morning and evening). The maximum dose per time shall not exceed 0.4mg, and the maximum daily dose shall not exceed 0.6mg. For patients with mild or moderate renal insufficiency, the single dose should not exceed 0.2 mg or the daily dose should not exceed 0.4 mg.

This product is an α2-receptor agonist, which is an imidazoline antihypertensive drug. Used for moderate and severe primary and secondary hypertension.

Because it inhibits the secretion and movement of the gastrointestinal tract, it is also suitable for hypertensive patients suffering from ulcer disease. The combination of this medicine and diuretics can significantly improve the efficacy. It is a powerful central antihypertensive drug and a second-line antihypertensive drug. It is mainly administered locally in ophthalmology. This product has the effect of reducing intraocular pressure, and does not affect the pupil and eye adjustment mechanism. It can constrict blood vessels in the eye, reduce the production of aqueous humor, and achieve the effect of reducing intraocular pressure. It starts to take effect 15 minutes after the eye drops and can maintain the effect for about 8 hours.

Standard:EP10
Assay content:97.5-102.0%

Exterior: White or almost while powder
Package: 1kg/bag or as required by customers


Product detail pictures:

Good quality Lurasidone Hydrochloride - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN detail pictures


Related Product Guide:

Now we have highly developed devices. Our items are exported towards the USA, the UK and so on, enjoying a great popularity among the customers for Good quality Lurasidone Hydrochloride - 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamin; – JIN DUN , The product will supply to all over the world, such as: Belgium, Mumbai, Ukraine, Since always, we adhering to the "open and fair, share to get, the pursuit of excellence, and creation of value"values, adhere to the"integrity and efficient, trade-oriented, best way , best valve" business philosophy. Together with our all over the world have branches and partners to develop new business areas, maximum common values. We sincerely welcome and together we share in global resources, opening up new career together with the chapter.
  • Timely delivery, strict implementation of the contract provisions of the goods, encountered special circumstances, but also actively cooperate, a trustworthy company!
    5 Stars By Dominic from European - 2017.06.22 12:49
    Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
    5 Stars By Moira from Brazil - 2017.09.26 12:12
    Write your message here and send it to us